These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3989044)

  • 21. Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease.
    Müller T; Amoiridis G; Kuhn W; Przuntek H
    Eur Neurol; 1999; 42(4):240-1. PubMed ID: 10567823
    [No Abstract]   [Full Text] [Related]  

  • 22. [A case of Hallervorden-Spatz syndrome with marked atrophy of the brainstem and cerebellum].
    Sodeyama N; Arai M; Sanjoh N; Orimo S; Tamaki M
    Rinsho Shinkeigaku; 1993 May; 33(5):525-9. PubMed ID: 8365059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nuclear magnetic resonance in the Hallervorden-Spatz syndrome].
    Vogl T; Bauer M; Seiderer M; Rath M
    Digitale Bilddiagn; 1984 Jun; 4(2):66-8. PubMed ID: 6467815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatosensory evoked potentials in Hallervorden-Spatz-neuroaxonal-dystrophy complex with dorsal column involvement.
    Mutoh K; Okuno T; Ito M; Mikawa H
    Clin Electroencephalogr; 1990 Apr; 21(2):58-66. PubMed ID: 2335040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations.
    Hayflick SJ; Hartman M; Coryell J; Gitschier J; Rowley H
    AJNR Am J Neuroradiol; 2006; 27(6):1230-3. PubMed ID: 16775270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult onset Hallervorden-Spatz disease with psychotic symptoms.
    del Valle-López P; Pérez-García R; Sanguino-Andrés R; González-Pablos E
    Actas Esp Psiquiatr; 2011; 39(4):260-2. PubMed ID: 21769749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients.
    Hájek M; Adamovicová M; Herynek V; Skoch A; Jírů F; Krepelová A; Dezortová M
    Eur Radiol; 2005 May; 15(5):1060-8. PubMed ID: 15565311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hallervorden-Spatz syndrome with acanthocytosis].
    Köhler B
    Monatsschr Kinderheilkd; 1989 Sep; 137(9):616-9. PubMed ID: 2811885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hallervorden Spatz syndrome: magnetic resonance findings. Case report].
    Farage L; Castro MA; Macedo TA; Assis MC; Souza LP; Freitas LO
    Arq Neuropsiquiatr; 2004 Sep; 62(3A):730-2. PubMed ID: 15334240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease.
    Schaffert DA; Johnsen SD; Johnson PC; Drayer BP
    Neurology; 1989 Mar; 39(3):440-2. PubMed ID: 2927660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hallervorden-Spatz disease with Lewy bodies].
    Antoine JC; Tommasi M; Chalumeau A; Jouvet-Telinge A; Bourrat C
    Rev Neurol (Paris); 1985; 141(12):806-9. PubMed ID: 3008295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hallervorden Spatz disease: MR imaging.
    Shah J; Patkar D; Patankar T; Krishnan A; Prasad S; Limdi J
    J Postgrad Med; 1999; 45(4):114-7. PubMed ID: 10734349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of magnetic resonance imaging in the diagnosis of Hallervorden-Spatz disease].
    Tabuchi M; Mori E; Yamadori A
    Rinsho Shinkeigaku; 1990 Sep; 30(9):972-7. PubMed ID: 2265508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hallervorden-Spatz disease in a psychiatric setting.
    Morphy MA; Feldman JA; Kilburn G
    J Clin Psychiatry; 1989 Feb; 50(2):66-8. PubMed ID: 2914882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up magnetic resonance imaging in Hallervorden-Spatz disease.
    Brouwer OF; Laboyrie PM; Peters AC; Vielvoye GJ
    Clin Neurol Neurosurg; 1992; 94 Suppl():S57-60. PubMed ID: 1320520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hallervorden-Spatz disease: MR and pathologic findings.
    Savoiardo M; Halliday WC; Nardocci N; Strada L; D'Incerti L; Angelini L; Rumi V; Tesoro-Tess JD
    AJNR Am J Neuroradiol; 1993; 14(1):155-62. PubMed ID: 8427079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of axonal involvement in Hallervorden-Spatz disease with magnetic resonance spectroscopy.
    Kitis O; Tekgul H; Erdemir G; Polat M; Serdaroglu G; Tosun A; Coker M; Gokben S
    J Neuroradiol; 2006 Apr; 33(2):129-32. PubMed ID: 16733428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Declining use of the Hallervorden-Spatz disease eponym in the last two decades.
    Zeidman LA; Pandey DK
    J Child Neurol; 2012 Oct; 27(10):1310-5. PubMed ID: 22832768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of magnetic resonance in the diagnosis of Hallervorden- Spatz disease: presentation of a case with familial history].
    Pérez Sempere A; Martínez Menéndez B; Villaverde Amundarain FJ; Calandre Hoenigsfeld L; Bermejo Pareja F
    Neurologia; 1990; 5(7):252-3. PubMed ID: 2288756
    [No Abstract]   [Full Text] [Related]  

  • 40. Hallervorden-Spatz syndrome.
    Vakili S; Drew AL; Von Schuching S; Becker D; Zeman W
    Arch Neurol; 1977 Dec; 34(12):729-38. PubMed ID: 201232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.